Tomas Kiselak, Director: Crescent Biopharma CBIO Buy · Filed 25/12/08

Trade details

Type: Insider buy
Amount: $18,237,600
Shares · price: 1,360,000 sh · $13.41 a share
Held after: 2,747,866 sh
Stock: Crescent Biopharma CBIO
Person: Tomas KiselakDirector
Trade date: 25/12/04
Filed: 25/12/08
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +98.0%

Crescent Biopharma trades, last 26 weeks

What else happened in Crescent Biopharma around then

Filed or reported within 30 days of the trade day · 25/11/04~01/03

Tomas Kiselak's recent trades

Tomas KiselakDirector
SellSpyre Therapeutics
Sell
Spyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
Tomas KiselakDirector
SellApogee Therapeutics
Sell
Apogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$6M
316,219 sh
$6M
Filed 25/10/09
Traded 25/10/07
Tomas KiselakDirector
BuyZenas BioPharma
Buy
Zenas BioPharma
ZBIO
$5.1M
300,000 sh
$5.1M
Filed 24/09/17
Traded 24/09/16